December 4, 2017 /

Capricor Therapeutics’ HOPE-Duchenne Clinical Trial (November 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy


Capricor Therapeutics’ HOPE-Duchenne Clinical Trial (November 2017)

Capricor Therapeutics joined PPMD for a webinar on November 30, 2017 to discuss the 12-month results from Capricor’s HOPE-Duchenne Clinical Trial, as well as the company’s plans for the HOPE-2 Clinical Trial in the first quarter of 2018, pending regulatory approval.

Research & Clinical Trial Webinars, Webinars
Posted on December 4, 2017
LinkedinPin ItWhatsApp

Join Our Mailing List